Τhe AFX unibody bifurcated unibody aortic endograft for the treatment of abdominal aortic aneurysms: current evidence and future perspectives

2019 ◽  
Vol 17 (1) ◽  
pp. 5-15
Author(s):  
Efstratios Georgakarakos ◽  
Georgios Ioannidis ◽  
Andreas Koutsoumpelis ◽  
Nikolaos Papatheodorou ◽  
Christos Argyriou ◽  
...  
2016 ◽  
Vol 13 (3) ◽  
pp. 253-262 ◽  
Author(s):  
Efstratios Georgakarakos ◽  
Christos V. Ioannou ◽  
George S. Georgiadis ◽  
Martin Storck ◽  
George Trellopoulos ◽  
...  

2020 ◽  
Vol 17 (12) ◽  
pp. 1249-1256
Author(s):  
Efstratios Georgakarakos ◽  
Nikolaos Papatheodorou ◽  
Christos Argyriou ◽  
Kalliopi-Maria Tasopoulou ◽  
Damianos Doukas ◽  
...  

VASA ◽  
2005 ◽  
Vol 34 (4) ◽  
pp. 217-223 ◽  
Author(s):  
Diehm ◽  
Schmidli ◽  
Dai-Do ◽  
Baumgartner

Abdominal aortic aneurysm (AAA) is a potentially fatal condition with risk of rupture increasing as maximum AAA diameter increases. It is agreed upon that open surgical or endovascular treatment is indicated if maximum AAA diameter exceeds 5 to 5.5cm. Continuing aneurysmal degeneration of aortoiliac arteries accounts for significant morbidity, especially in patients undergoing endovascular AAA repair. Purpose of this review is to give an overview of the current evidence of medical treatment of AAA and describe prospects of potential pharmacological approaches towards prevention of aneurysmal degeneration of small AAAs and to highlight possible adjunctive medical treatment approaches after open surgical or endovascular AAA therapy.


2021 ◽  
Vol 2021 ◽  
pp. 1-21
Author(s):  
Yanshuo Han ◽  
Hao Zhang ◽  
Ce Bian ◽  
Chen Chen ◽  
Simei Tu ◽  
...  

Abdominal aortic aneurysms (AAAs) have posed a great threat to human life, and the necessity of its monitoring and treatment is decided by symptomatology and/or the aneurysm size. Accumulating evidence suggests that circular RNAs (circRNAs) contribute a part to the pathogenesis of AAAs. circRNAs are novel single-stranded RNAs with a closed loop structure and high stability, having become the candidate biomarkers for numerous kinds of human disorders. Besides, circRNAs act as molecular “sponge” in organisms, capable of regulating the transcription level. Here, we characterize that the molecular mechanisms underlying the role of circRNAs in AAA development were further elucidated. In the present work, studies on the biosynthesis, bibliometrics, and mechanisms of action of circRNAs were aims comprehensively reviewed, the role of circRNAs in the AAA pathogenic mechanism was illustrated, and their potential in diagnosing AAAs was examined. Moreover, the current evidence about the effects of circRNAs on AAA development through modulating endothelial cells (ECs), macrophages, and vascular smooth muscle cells (VSMCs) was summarized. Through thorough investigation, the molecular mechanisms underlying the role of circRNAs in AAA development were further elucidated. The results demonstrated that circRNAs had the application potential in the diagnosis and prevention of AAAs in clinical practice. The study of circRNA regulatory pathways would be of great assistance to the etiologic research of AAAs.


F1000Research ◽  
2017 ◽  
Vol 6 ◽  
pp. 1549
Author(s):  
Norman R Hertzer

Ruptured abdominal aortic aneurysms have an alarmingly high mortality rate that often exceeds 50%, even when patients survive long enough to be transported to hospitals. Historical data have shown that ruptures are especially likely to occur with aneurysms measuring ≥6 cm in diameter, but there are so many exceptions to this that several randomized clinical trials have been done in an attempt to determine whether smaller aneurysms should be repaired electively as soon as they are discovered. More recently, further trials have been conducted in order to compare the relative benefits and disadvantages of modern endovascular aneurysm repair to those of traditional open surgery. This review summarizes current evidence from randomized trials and large population-based datasets regarding two questions that are uppermost in the mind of virtually every patient who is found to have an abdominal aortic aneurysm. Should it be fixed? What are the risks?


2019 ◽  
Vol 10 (1) ◽  
Author(s):  
Gianluigi Orgera ◽  
Marcello Andrea Tipaldi ◽  
Florindo Laurino ◽  
Pierleone Lucatelli ◽  
Alberto Rebonato ◽  
...  

Abstract The presence of endoleaks remains one of the main drawbacks of endovascular repair of abdominal aortic aneurysms leading to the increase of the size of the aneurysmal sac and in most of the cases to repeated interventions. A variety of devices and percutaneous techniques have been developed so far to prevent and treat this phenomenon, including sealing of the aneurysmal sac, endovascular embolisation, and direct sac puncture. The aim of this review is to analyse the indications, the effectiveness, and the future perspectives for the prevention and treatment of endoleaks after endovascular repair of abdominal aortic aneurysms.


Angiology ◽  
2009 ◽  
Vol 61 (2) ◽  
pp. 137-144 ◽  
Author(s):  
Athanasios Saratzis ◽  
George D. Kitas ◽  
Nikolaos Saratzis ◽  
Nikolaos Melas

2001 ◽  
Vol 71 (6) ◽  
pp. 341-344
Author(s):  
Johanna Rose ◽  
Ian Civil ◽  
Timothy Koelmeyer ◽  
David Haydock ◽  
Dave Adams

VASA ◽  
2012 ◽  
Vol 41 (1) ◽  
pp. 3-4
Author(s):  
Diehm ◽  
Diehm ◽  
Dick

Sign in / Sign up

Export Citation Format

Share Document